1. Home
  2. AGX vs RDY Comparison

AGX vs RDY Comparison

Compare AGX & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$589.09

Market Cap

8.4B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$12.19

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AGX
RDY
Founded
1961
1984
Country
United States
India
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
9.9B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
AGX
RDY
Price
$589.09
$12.19
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$409.50
$16.90
AVG Volume (30 Days)
273.0K
2.9M
Earning Date
03-26-2026
05-12-2026
Dividend Yield
0.32%
0.52%
EPS Growth
58.37
N/A
EPS
3.24
N/A
Revenue
$944,606,000.00
N/A
Revenue This Year
$33.81
$7.72
Revenue Next Year
$20.97
$3.50
P/E Ratio
$178.46
$18.67
Revenue Growth
8.06
N/A
52 Week Low
$197.00
$11.36
52 Week High
$805.75
$15.67

Technical Indicators

Market Signals
Indicator
AGX
RDY
Relative Strength Index (RSI) N/A 42.55
Support Level N/A $11.47
Resistance Level N/A $13.95
Average True Range (ATR) 0.00 0.18
MACD 0.00 0.09
Stochastic Oscillator 0.00 58.00

Price Performance

Historical Comparison
AGX
RDY

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Teledata, out of which Power Services derives the majority of revenue.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: